Artesunate shows potent anti-tumor activity in B-cell lymphoma

Artesunate shows potent anti-tumor activity in B-cell lymphoma

Abstract Background Although chemo-immunotherapy has led to an improved overall survival for most B-cell lymphoma types, relapsed and refractory disease remains a challenge. The malaria drug artesunate has previously been identified as a growth suppressor in some cancer types and was tested as a new...

Full description

Bibliographic Details
Main Authors: Thea Kristin Våtsveen, Marit Renée Myhre, Chloé Beate Steen, Sébastien Wälchli, Ole Christian Lingjærde, Baoyan Bai, Pierre Dillard, Theodossis A. Theodossiou, Toril Holien, Anders Sundan, Else Marit Inderberg, Erlend B. Smeland, June Helen Myklebust, Morten P. Oksvold
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Journal of Hematology & Oncology
Subjects:
Artemisinin
B-cell lymphoma
Drug screen
ER stress
UPR
Online Access:http://link.springer.com/article/10.1186/s13045-018-0561-0

Internet

http://link.springer.com/article/10.1186/s13045-018-0561-0

Similar Items